Wijayasinghe, Nelun
Novo Nordisk (Denmark)
2 papers on CoChat
Most cited papers
- Verified
Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial.
Rodbard, H. W., Lingvay, I., Reed, J., de la Rosa, R., Rose, L., Sugimoto, D., Araki, E., Chu, P.-L., Wijayasinghe, N., & Norwood, P. (2018) · The Journal of Clinical Endocrinology & Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 412
- Verified
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
Vilsbøll, T., Bain, S. C., Leiter, L. A., Lingvay, I., Matthews, D., Simó, R., Helmark, I. C., Wijayasinghe, N., & Larsen, M. (2018) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementRetinal Diseases and Treatments
Cited by 318
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free